These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8509218)

  • 1. Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents.
    Tagliabue G; Pifferi A; Balconi G; Mascellani E; Geroni C; D'Incalci M; Ubezio P
    Int J Cancer; 1993 May; 54(3):435-42. PubMed ID: 8509218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
    Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M
    Int J Cancer; 1993 Jan; 53(2):308-14. PubMed ID: 8425770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of glutathione S-transferases on cellular glutathione determination by flow cytometry using monochlorobimane.
    Ublacker GA; Johnson JA; Siegel FL; Mulcahy RT
    Cancer Res; 1991 Apr; 51(7):1783-8. PubMed ID: 2004362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric monitoring of glutathione content and anthracycline retention in tumor cells.
    Nair S; Singh SV; Krishan A
    Cytometry; 1991; 12(4):336-42. PubMed ID: 1648468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.
    Hrubisko M; Kysela B; Kuliffay P
    Neoplasma; 1989; 36(4):401-10. PubMed ID: 2770927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.
    Geroni C; Pesenti E; Broggini M; Belvedere G; Tagliabue G; D'Incalci M; Pennella G; Grandi M
    Br J Cancer; 1994 Feb; 69(2):315-9. PubMed ID: 8297727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells.
    Hromas RA; Andrews PA; Murphy MP; Burns CP
    Cancer Lett; 1987 Jan; 34(1):9-13. PubMed ID: 3802072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
    Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells.
    Strandberg MC; Bresnick E; Eastman A
    Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
    Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation, intracellular distribution and efflux of glutathione-bimane conjugates in drug-sensitive and -resistant MCF-7 cells.
    Millis KK; Lesko SA; Gamcsik MP
    Cancer Chemother Pharmacol; 1997; 40(2):101-11. PubMed ID: 9182830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of flow cytometry and monochlorobimane to quantitate intracellular glutathione concentrations in feline leukocytes.
    Webb C; Bedwell C; Guth A; Avery P; Dow S
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):129-40. PubMed ID: 16730073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Nicolson MC; Orr RM; O'Neill CF; Harrap KR
    Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein.
    Bohácová V; Sulová Z; Dovinová I; Poláková E; Barancík M; Uhrík B; Orlický J; Breier A
    Toxicol In Vitro; 2006 Dec; 20(8):1560-8. PubMed ID: 16962737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
    Pezzoni G; Grandi M; Biasoli G; Capolongo L; Ballinari D; Giuliani FC; Barbieri B; Pastori A; Pesenti E; Mongelli N
    Br J Cancer; 1991 Dec; 64(6):1047-50. PubMed ID: 1764367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
    Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
    Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.